Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 1b study from GELTAMO group

  1. Martín, A.
  2. Redondo, A.M.
  3. Dlouhy, I.
  4. Salar, A.
  5. González-Barca, E.
  6. Canales, M.
  7. Montes-Moreno, S.
  8. Ocio, E.M.
  9. López-Guillermo, A.
  10. Caballero, D.
Aldizkaria:
British Journal of Haematology

ISSN: 1365-2141,  0007-1048

Argitalpen urtea: 2016

Alea: 173

Zenbakia: 2

Orrialdeak: 245-252

Mota: Artikulua

DOI: 10.1111/BJH.13945 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus